340B Drug Pricing Program
AHA responds to Information Collection Request about the Health Resources and Services Administration’s proposed 340B Rebate Model Program.
The Centers for Medicare & Medicaid Services July 14 issued a proposed rule that would update physician fee schedule (PFS) payments for calendar year (CY) 2027.
The AHA, America’s Essential Hospitals, the Children’s Hospital Association, the Association of American Medical Colleges, and the American Society of Health-System Pharmacists today filed a friend-of-the-court brief supporting the Department of Health and Human Services’ motion to dismiss AbbVie’s…
The Health Resources and Services Administration announced that 340B covered entities purchased $100 billion in outpatient drugs under the federal 340B Drug Pricing Program in calendar year 2025.
The AHA shares the goal of making healthcare more affordable and accessible. We recently released actionable, achievable strategies that will help drive care transformation and make care more affordable.
The AHA today released legislative advisories on a 340B bill introduced by a bipartisan House working group and a legislative discussion draft introduced in the Senate.
On June 29, Sen. Bill Cassidy, R-La., unveiled a legislative discussion draft titled the 340B Drug Pricing Integrity and Affordability for Patients Act.
Reps. Scott Peters, D-Calif., and John Joyce, R-Pa., introduced the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act, or SECURE 340B Act.
If you haven’t done so yet, please register for an AHA 340B Advocacy Alliance call on July 8 at 3 p.m. ET to hear the latest updates on the 340B Drug Pricing Program.
As a private, not-for-profit organization dedicated to enhancing the lives of the people it serves, Citizens Health is a trusted source of health and well-being for the local community.